type here...

CATEGORIES

Editors Choice

LATEST

1...122123124...150Page 123 of 150

TRENDING

EDITORS CHOICE

The Surprising Behavior That Raises Prostate Cancer Risk by Nearly Half

Michael Hunter, MD -
According to the American Cancer Society, prostate cancer is the most common cancer among men and the second-leading cause of cancer deaths.

The Future of Health Information and Innovation: A Conversation with HIMSS CEO Hal Wolf

Gil Bashe, Medika Life Editor -
At a time of great change, HIMSS continues to be a pivotal voice bridging technology, policy and patient care

Long Covid is Common After Mild Covid-19 Infection

Stephen Schimpff, MD MACP -
“I was vaccinated but developed a Covid infection shortly before being eligible for a booster shot. I had a fever and fatigue which lasted...

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Medika Life -
Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories